Fig. 1 · Structure
Documents & Downloads
Rivastigmine metabolite
AChE Inhibitor
Rivastigmine metabolite (NAP 226-90) is an acetylcholinesterase (AChE) inhibitor that plays a significant role in the modulation of cholinergic neurotransmission. This compound is a key metabolite formed in the kidney and is of particular interest for research into Alzheimer's Disease. Its inhibitory action on AChE highlights its potential for studying therapeutic approaches in neurodegenerative conditions characterized by cholinergic deficits.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 139306-10-8 |
| Applications | AChE Inhibitor |
| Formula | C10H15NO |
| Molecular Weight | 165.23 |
| Synonyms | NAP 226-90 |
| SMILES | OC1=CC=CC([C@@H](N(C)C)C)=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.